Boston Biodevelopment speaks at DIA Europe 2025

It's a wrap for DIA Europe 2025! Great energy, excellent learnings, and wonderful colleagues old and new made this a fantastic experience for the Boston Biodevelopment team who sponsored and exhibited at the conference. Life science innovation is thriving in Europe and we are delighted to partner with European companies looking to enter and navigate the US regulatory landscape with our US Agent services and our highly-experienced regulatory experts.

Additionally we’d like to thank DIA Europe 2025 and all the attendees that made our talk "Turbulence Across the Atlantic: Navigating Post-Election Uncertainty at FDA" the highest attended Innovation Hub session at the conference! Our executive team - Helena Correia, Angela Nelson, and James Rawls - wanted to bring timely and useful content to this very knowledgeable audience and we appreciate your positive feedback.